BPG is committed to discovery and dissemination of knowledge
Editorial
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 7, 2024; 30(17): 2298-2301
Published online May 7, 2024. doi: 10.3748/wjg.v30.i17.2298
Surgical cystogastrostomy: Is it still worthwhile?
Kin Pan Au, Kenneth Siu Ho Chok
Kin Pan Au, Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong 999077, China
Kenneth Siu Ho Chok, Department of Surgery, The Chinese University of Hong Kong, Hong Kong 999077, China
Author contributions: Chok KSH initiated the idea of writing up the Editorial; Au KP and Chok KSH contributed to the manuscript writing equally; Chok KSH critically revised the final paper.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Kenneth Siu Ho Chok, FACS, FRCS (Ed), MBBS, MD, MS, Professor, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong 999077, China. kennethchok@gmail.com
Received: February 12, 2024
Revised: March 10, 2024
Accepted: April 15, 2024
Published online: May 7, 2024
Processing time: 82 Days and 20.7 Hours
Core Tip

Core Tip: Treatment options of peripancreatic fluid collection (PFC) include percutaneous drainage, endoscopy, and surgery. Percutaneous drainage is noted for its low risk profile, while endoscopic cystogastrostomy is more effective due to the wider orifice of the metallic stent. Surgical cystogastrostomy is a definitive treatment with a reduced need for reintervention, especially for cases with extensive collections and significant necrosis. The choice of treatment modality should be tailored to individual patient characteristics and disease factors, considering the expertise available.